WINDTREE THERAPEUTICS INC /DE/ Quarterly Interest Expense in USD from Q2 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Interest Expense history and growth rate from Q2 2012 to Q1 2024.
  • Windtree Therapeutics Inc /De/ Interest Expense for the quarter ending March 31, 2024 was $13K, a 8.33% increase year-over-year.
  • Windtree Therapeutics Inc /De/ Interest Expense for the twelve months ending March 31, 2024 was $51K, a 1.92% decline year-over-year.
  • Windtree Therapeutics Inc /De/ annual Interest Expense for 2023 was $50K, a 5.66% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Interest Expense for 2022 was $53K, a 53.5% decline from 2021.
  • Windtree Therapeutics Inc /De/ annual Interest Expense for 2021 was $114K, a 8.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $51K $13K +$1K +8.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $50K $12K -$1K -7.69% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $51K $13K -$1K -7.14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $52K $13K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $52K $12K -$1K -7.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $53K $13K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $53K $14K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $53K $13K -$33K -71.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $86K $13K -$28K -68.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $114K $13K +$9K +225% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $105K $14K -$32K -69.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $137K $46K +$15K +48.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $122K $41K -$3K -6.82% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $125K $4K -$133K -97.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $258K $46K -$59K -56.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $317K $31K -$86K -73.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $403K $44K -$92K -67.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $495K $137K -$630K -82.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $1.13M $105K -$355K -77.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.48M $117K +$25K +27.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.46M $136K +$46K +51.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.41M $767K +$782K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $627K $460K -$192K -29.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $819K $92K -$523K -85% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.34M $90K -$521K -85.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $1.86M -$15K -$626K -102% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 $2.49M $652K +$4K +0.62% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.49M $615K -$22K -3.45% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.51M $611K -$11K -1.77% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $2.52M $611K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $648K -$847K -56.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $637K -$623K -49.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $622K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 $1.5M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $1.26M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q3 2013 $353K +$349K +8725% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $343K +$339K +8475% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-08
Q3 2012 $4K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $4K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.